The indirect nuclear talks between the U.S. and Iran mediated by Oman were ‘very good,’…
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth
Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central…
